Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Current Assets (2021 - 2025)

Zymeworks' Current Assets history spans 3 years, with the latest figure at $374.6 million for Q3 2023.

  • For Q3 2023, Current Assets rose 96.5% year-over-year to $374.6 million; the TTM value through Sep 2023 reached $374.6 million, up 96.5%, while the annual FY2022 figure was $544.7 million, 88.99% up from the prior year.
  • Current Assets for Q3 2023 was $374.6 million at Zymeworks, down from $420.3 million in the prior quarter.
  • Across five years, Current Assets topped out at $544.7 million in Q4 2022 and bottomed at $190.7 million in Q3 2022.
  • The 3-year median for Current Assets is $397.5 million (2023), against an average of $374.2 million.
  • The largest annual shift saw Current Assets skyrocketed 88.99% in 2022 before it skyrocketed 96.5% in 2023.
  • A 3-year view of Current Assets shows it stood at $288.2 million in 2021, then surged by 88.99% to $544.7 million in 2022, then plummeted by 31.22% to $374.6 million in 2023.
  • Per Business Quant, the three most recent readings for ZYME's Current Assets are $374.6 million (Q3 2023), $420.3 million (Q2 2023), and $426.4 million (Q1 2023).